Your browser doesn't support javascript.
loading
Endometrial preparation does not affect the risk of hypertensive disorders of pregnancy in low-risk women undergoing frozen embryo transfer.
Dallagiovanna, Chiara; Cappellari, Michela; D'Ambrosi, Francesco; Reschini, Marco; Kordas, Karina; Li Piani, Letizia; Filippi, Francesca; Somigliana, Edgardo.
Afiliación
  • Dallagiovanna C; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Cappellari M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • D'Ambrosi F; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Reschini M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Kordas K; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Li Piani L; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Filippi F; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Somigliana E; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Gynecol Endocrinol ; 38(3): 238-242, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34382914
OBJECTIVE: Frozen embryo transfer (FET) is associated with a higher risk of hypertensive disorders in pregnancy. The objective of the present study is to evaluate the effect of different protocols of endometrial preparation on the risk of these disorders. METHODS: We conducted a retrospective cohort study on 594 singleton pregnancies achieved by embryo transfer of single frozen-thawed blastocysts. Women with preexisting risk factors for hypertensive disorders were excluded. Women were divided into two groups according to the endometrial preparation protocol: either natural cycle (n = 495) or programming cycle with hormonal replacement therapy (n = 97). The primary outcome was the frequency of hypertensive disorders in pregnancy: specifically, gestational hypertension and preeclampsia. RESULTS: No differences emerged between women following the natural cycle and those following the programming cycle in the frequency of gestational hypertension (5 vs. 4%) and preeclampsia (1.1 vs. 1.2%). No impact emerged also after multivariate analyses. CONCLUSIONS: Women receiving hormonal replacement therapy have the same risk of gestational hypertension and preeclampsia as women following natural cycles when considering low-risk singleton pregnancies.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipertensión Inducida en el Embarazo Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Gynecol Endocrinol Asunto de la revista: ENDOCRINOLOGIA / GINECOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipertensión Inducida en el Embarazo Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Gynecol Endocrinol Asunto de la revista: ENDOCRINOLOGIA / GINECOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia